[go: up one dir, main page]

AU6171196A - Therapeutic uses of ta99 - Google Patents

Therapeutic uses of ta99

Info

Publication number
AU6171196A
AU6171196A AU61711/96A AU6171196A AU6171196A AU 6171196 A AU6171196 A AU 6171196A AU 61711/96 A AU61711/96 A AU 61711/96A AU 6171196 A AU6171196 A AU 6171196A AU 6171196 A AU6171196 A AU 6171196A
Authority
AU
Australia
Prior art keywords
therapeutic uses
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61711/96A
Inventor
Alan N. Houghton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Publication of AU6171196A publication Critical patent/AU6171196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU61711/96A 1995-06-07 1996-06-07 Therapeutic uses of ta99 Abandoned AU6171196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47977495A 1995-06-07 1995-06-07
US479774 1995-06-07
PCT/US1996/010038 WO1996040249A1 (en) 1995-06-07 1996-06-07 Therapeutic uses of ta99

Publications (1)

Publication Number Publication Date
AU6171196A true AU6171196A (en) 1996-12-30

Family

ID=23905371

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61711/96A Abandoned AU6171196A (en) 1995-06-07 1996-06-07 Therapeutic uses of ta99

Country Status (2)

Country Link
AU (1) AU6171196A (en)
WO (1) WO1996040249A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2268672A1 (en) 2008-03-12 2011-01-05 Imclone LLC Anti-tyrp1 antibodies
US9844582B2 (en) 2012-05-22 2017-12-19 Massachusetts Institute Of Technology Synergistic tumor treatment with extended-PK IL-2 and therapeutic agents
US20150017120A1 (en) * 2013-06-13 2015-01-15 Massachusetts Institute Of Technology Synergistic tumor treatment with extended-pk il-2 and adoptive cell therapy
EP3066212B1 (en) * 2013-11-06 2020-04-01 Universite de Rennes 1 Tyrp1, a natural mirna sponge, and its use in managing human melanoma aggressiveness

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162181A (en) * 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same

Also Published As

Publication number Publication date
WO1996040249A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
AU5478496A (en) Therapeutic amides
AU5268696A (en) Novel compounds and methods for therapy
AU6282196A (en) Therapeutic glove
AU7443496A (en) Treatment of migraine
AU4780596A (en) Hemi-wheeled walker
AU7867994A (en) Hemofiltration of mediator-related diseases
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU4329396A (en) Use of 3,4-diphenylchromans
GB9512290D0 (en) Uses of polyhexanide
AU6328696A (en) Treatment of hemoglobinopathies
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
AU5381696A (en) Synthesis of bis-indolylmaleimides
AU5119296A (en) Magnetotherapy unit
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU1181897A (en) Medical use of proteases
AU6829696A (en) Treatment of solutions
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AUPN727595A0 (en) Therapeutic compositions
AU5010196A (en) Therapeutic benzoxazoles
AU6171196A (en) Therapeutic uses of ta99
AU4670696A (en) Diagnosis of toxicoinfectious clostridiosis
AU5697996A (en) Peptidyl compounds and their therapeutic use
AU4446396A (en) Use of dihydroxyacetone